findmyKOL

Michael Tsang, MD

Basic profile

Cardiovascular Disease

ORCIDNone on fileNPI
RegionOakland, CA · WestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationNot yet indexedOnline presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Michael Tsang is a Cardiology physician.

Overview

Scholarship

indexed output and impact (OpenAlex)

Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →

Clinical & industry

trials, payments and federal funding
8companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

350 30th St Ste 411
Oakland, CA 94609

Telephone

510-204-8383

Provider last certified this registry record 8 May 2024.

View the NPPES registry record

Industry payments

8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    77.9%
    Statin16.5%
    Atorvastatin Calcium46%Rosuvastatin Calcium41%Simvastatin6%Pravastatin Sodium4%Lovastatin2%
    Part D<11 patients
    Beta blocker15.5%
    Metoprolol Succinate54%Carvedilol24%Metoprolol Tartrate10%Nebivolol Hcl7%Atenolol3%Labetalol Hcl3%
    Part D<11 patients

    + 16 more classes in this area

  • Blood & clotting

    17%
    Factor Xa inhibitor16%
    Eliquis80%Xarelto20%
    Part D121 patients
    P2Y12 inhibitor1%
    Clopidogrel100%
    Part D15 patients
  • Metabolism & gastrointestinal

    4.4%
    SGLT2 inhibitor2.7%
    Jardiance52%Farxiga48%
    Part D17 patients
    Potassium supplement1.6%
    Potassium Chloride100%
    Part D21 patients
Where care is delivered (Part B)30.7% facility · 69.3% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”